A randomized double-blind multi-dose placebo-controlled study to evaluate the efficacy safety and tolerability of GSK2330672 administration for the treatment of pruritus in patients with primary biliary cholangitis

Research Summary

Research Overview
Sponsor Glaxo Smith Klein
Project Status Open
Proposed End Date 31/10/2019
Study Run through CRF? Yes
Target number of patients agreed to recruit 2
Recruitment so far 4